Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View ReportEarly and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…
View ReportIPC’s Disease Severity Working Group has refined the criteria for mild, moderate, and severe psoriasis based on the…
View ReportA new study reveals systemic inflammation mediates the link between psoriasis severity and cardiovascular disease,…
View ReportThe International Psoriasis Council (IPC) joined IFPA and regional leaders at the IFPA Forum Americas in Bogotá to…
Read MoreThe IPC's global network of experts volunteers annually to educate and train physicians, improving care for individuals…
Read MoreDr. Tiago Torres examines palmoplantar and nail psoriasis and further investigates the treatment options and therapies…
Watch VideoThe program chair and faculty address questions from IPC Global Webinar 3: "The Full Cycle of Psoriasis Care in 2024:…
Watch VideoThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreDr. Tiago Torres leads a panel of global experts in psoriasis and eczema as they discuss the first half of the…
Watch VideoThis report from the 53rd Annual ESDR Meeting in Lisbon covers key presentations on psoriasis, including updates from…
Read MoreThe 53rd Annual European Society for Dermatological Research (ESDR) Meeting was held in Lisbon, Portugal, from…
View ReportIPC GLOBAL WEBINAR SERIES Program chairs: Curdin Conrad, Switzerland Program faculty: Cristina Echeverría, Argentina…
EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH ANNUAL MEETING (ESDR) | LISBON, PORTUGAL Program chairs: Johann…
Gain expert insights into two recent publications shedding light on the molecular mechanisms of IL-23/IL-17…
Read MoreACADEMIA ESPAÑOLA DE DERMATOLOGÍA Y VENEREOLOGÍA (AEDV) CONGRESS | MADRID, SPAIN Thursday, January 18 18:00 -…
PHILIPPINES PSORIASIS SYMPOSIUM | VIRTUAL Thursday, October 5 12:00-14:15 CEST 6:00-08:15 EDT 18:00-20:15…
The prognosis and maintenance of response after treatment discontinuation following remission lack proper…
Read MoreThe European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreLa psoriasis y la tuberculosis han ido de la mano durante mucho tiempo. Esto es especialmente cierto en ciertas partes…
View Report| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.